|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,288.50 JPY | +6.00% |
|
-0.30% | +9.34% |
| 01:25pm | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| 06/08 | Merck's Keytruda Gets Canadian Approval to Treat Muscle-Invasive Bladder Cancer | MT |
| Market Cap | 4,103B 25.9B 22.48B 21.05B 19.25B 36.35B 2,467B 36.82B 246B 96.64B 1,233B 97.25B 95.14B | P/E 2027 * |
11.4x | P/E 2028 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 4,114B 25.97B 22.54B 21.11B 19.31B 36.45B 2,474B 36.92B 247B 96.9B 1,236B 97.52B 95.4B | EV / Sales 2027 * |
1.8x | EV / Sales 2028 * | 1.75x |
| Free-Float |
98.88% | Yield 2027 * |
3.51% | Yield 2028 * | 3.62% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +6.00% | ||
| 1 week | -0.30% | ||
| Current month | +3.93% | ||
| 1 month | +6.34% | ||
| 3 months | +3.69% | ||
| 6 months | -5.47% | ||
| Current year | +9.34% |
| 1 week | 2,125 |  | 2,312 |
| 1 month | 2,109 | | 2,312 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.00% | -0.30% | +44.80% | +14.94% | 24.57B | |
| +1.89% | -1.49% | +55.62% | +165.18% | 1,043B | |
| -0.24% | -3.22% | +50.51% | +52.02% | 621B | |
| -0.95% | -7.38% | +22.83% | +65.08% | 435B | |
| 0.00% | +0.83% | +42.80% | +37.60% | 361B | |
| +0.58% | -3.51% | +31.12% | +40.54% | 293B | |
| -1.55% | -9.78% | +5.61% | +8.62% | 251B | |
| -0.73% | +4.44% | +34.91% | +66.41% | 220B | |
| -0.24% | -13.15% | -4.02% | -44.69% | 201B | |
| -0.68% | -1.41% | +16.36% | +66.32% | 164B | |
| Average | +0.43% | -4.02% | +30.05% | +47.20% | 361.37B | |
| Weighted average by Cap. | +0.31% | -3.80% | +37.62% | +76.76% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,288B 14.45B 12.54B 11.74B 10.74B 20.27B 1,376B 20.54B 137B 53.89B 688B 54.24B 53.06B | 2,101B 13.26B 11.51B 10.78B 9.86B 18.61B 1,263B 18.85B 126B 49.48B 631B 49.8B 48.71B |
| Net income | 358B 2.26B 1.96B 1.84B 1.68B 3.18B 216B 3.22B 21.51B 8.44B 108B 8.5B 8.31B | 341B 2.15B 1.87B 1.75B 1.6B 3.02B 205B 3.06B 20.44B 8.02B 102B 8.07B 7.9B |
| Net Debt | 11.12B 70.22M 60.93M 57.06M 52.19M 98.53M 6.69B 99.82M 668M 262M 3.34B 264M 258M | -418B -2.64B -2.29B -2.14B -1.96B -3.7B -251B -3.75B -25.07B -9.84B -126B -9.9B -9.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | JPY 2,288.50 | +6.00% | 10,352,900 |
| 05/08/26 | JPY 2,159.00 | -0.44% | 5,388,800 |
| 04/08/26 | JPY 2,168.50 | -0.34% | 6,719,900 |
| 03/08/26 | JPY 2,176.00 | -1.18% | 7,373,300 |
| 31/07/26 | JPY 2,202.00 | -3.72% | 8,229,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
